Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know [Yahoo! Finance]
Vertex Pharmaceuticals Incorporated (VRTX)
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.vrtx.com
Company Research
Source: Yahoo! Finance
Shares of the drugmaker have appreciated by 1.68% over the course of the past month, underperforming the Medical sector's gain of 3.34% and the S&P 500's gain of 3.67%. The investment community will be paying close attention to the earnings performance of Vertex Pharmaceuticals in its upcoming release. In that report, analysts expect Vertex Pharmaceuticals to post earnings of $4.11 per share. This would mark year-over-year growth of 0.74%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.68 billion, up 7.83% from the year-ago period. For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.05 per share and a revenue of $10.74 billion, signifying shifts of -99.67% and +8.87%, respectively, from the last year. Furthermore, it would be beneficial for investors to monitor any recent shifts in analyst projections for Vertex Pharmaceuticals. These revisions typically reflect the latest short-term business trends, which can change
Show less
Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
News
- Jupiter Endovascular treats first patients with Vertex system in SPIRARE I study [Yahoo! Finance]Yahoo! Finance
- Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $431.00 price target on the stock.MarketBeat
- Vertex Pharmaceuticals Incorporated (VRTX) Management presents at Cantor Global Healthcare Conference (Transcript) [Seeking Alpha]Seeking Alpha
- Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics [Yahoo! Finance]Yahoo! Finance
- Is Most-Watched Stock Vertex Pharmaceuticals Incorporated (VRTX) Worth Betting on Now? [Yahoo! Finance]Yahoo! Finance
VRTX
Earnings
- 8/1/24 - Miss
VRTX
Sec Filings
- 9/4/24 - Form 4
- 9/4/24 - Form 4
- 8/30/24 - Form 144
- VRTX's page on the SEC website